Multidisciplinary Patient-Centered Care Delivered Remotely Improves Glycemic Outcomes and Patient Reported Outcomes

Lack of access to specialized multidisciplinary teams familiar with advanced technologies for T1D care remains a barrier to achieving glycemic targets and patient-centered goals. Since launching a T1D virtual clinic in 2018, we have treated 123 adults with T1D who had previously received standard care. There was a significant improvement in glycemic indices and in validated and self-originated patient reported outcome measures at 6 and 12 months as compared to baseline (table 1). Mean baseline HbA1c was 8.1%, and this improved to 7.6% and 7.3% at 6 and 12 months respectively (p< 0.001). Average sensor glucose declined by 5.5% over 6 months (p<0.001). While TIR increased significantly by 10.4% over 12 months, TBR decreased. Diabetes Treatment Satisfaction Questionnaire scores improved significantly, as did Diabetes Self-Management Questionnaire scores. According to a 5-point scale survey, there was improved satisfaction with the availability of the physician, nurse and dietitian beyond the appointment time and with the guidance received beyond scheduled visits. Remote care was associated with improved satisfaction regarding saving time and reducing expenses by curtailing office visits. In conclusion, transitioning from a standard T1D care to a virtual clinic is associated with improved glycemic control, higher patient satisfaction and better self-care behaviors. Disclosure N.Minsky: None. A.Tirosh: Advisory Panel; Medtronic, Novo Nordisk, Sanofi, Eli Lilly and Company, Research Support; Medtronic, Sanofi, Speaker's Bureau; Medtronic, Novo Nordisk, Sanofi, Eli Lilly and Company. O.Tamir: Other Relationship; Novo Nordisk. G.Aharon-hananel: Speaker's Bureau; Eli Lilly and Company, Novo Nordisk. A.Jabarin: None. L.Arnon: None. N.Morozov: None. D.Halperin: None. M.Shalom: None. E.Tarshish: None. T.Kolobov: None. Funding European Foundation for the Study of Diabetes (9366); Israel Ministry of Health